Forty51 Advisors AG is a venture advisory firm focused on early-stage life sciences and biotechnology investments and on venture building. It acts as a lead or co-lead investor in initial institutional financings and supports the creation and development of biotech start-ups.
AI-generated
Offering
Products & services
Industry:Financial Services
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Company Building for European biotech companies with a clear clinical perspective; support for Venture Creation, incubation and the building of stronger companies.
Early-stage investments in biotech
Early-stage investments in European biotech opportunities as the first institutional investor, as lead or co-lead investor in the first institutional financing round.
Venture Creation Support
Venture Creation Support with hands-on guidance for entrepreneurs, bringing in many years of pharma experience and support in building and maturing biotech companies.
Diligence and target evaluation
Diligence and target evaluation for early biotech opportunities, including in-depth review of targets and assessment of development programs.
Knowledge
No knowledge articles yet
Once Forty51 Advisors AG has claimed this profile, we'll publish editorial articles and case studies here together.